natgillin/translations-raw huggingface dataset:
Spironolactone and its active metabolites (including 7α-thiomethyl-spironolactone and canrenone) act as specific antagonists of aldosterone, and exert their effects by binding competitively to the mineralocorticoid receptor located in the kidneys, heart and blood vessels. 
Spironolakton in njegovi aktivni metaboliti (vključno z 7α-tiometil-spironolaktonom in kanrenonom) delujejo kot specifični antagonisti aldosterona, ki svoje učinke kažejo s kompetitivno vezavo na mineralokortikoidne receptorje v ledvicah, srcu in krvnih žilah.
Do not use in conjunction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in dogs with renal insufficiency (kidney impairment/dysfunction). 
Ne uporabite skupaj z nesteroidnimi protivnetnimi zdravili (NSAID) pri psih z insuficienco ledvic (ledvično okvaro/disfunkcijo).
Partially used tablets should be stored in the original blister and used within 7 days. 
Delno uporabljene tablete shranjujte v originalnem pretisnem omotu in jih uporabite v 7 dneh.
There may be a dose related hypertrophy of the adrenal zona glomerulosa at high dose rates. 
Pri visokih odmerkih se lahko pojavi od odmerka odvisna hipertrofija adrenalne zone glomerulose.
Unlike in humans, an increased incidence of hyperkalaemia was not observed in clinical trials performed in dogs with this combination. 
Za razliko od ljudi, se pogostost povečane hiperkalemije ni pokazala pri kliničnih testiranjih pri psih v omenjeni kombinaciji.
Steady-state conditions are reached by day 2. 
Stalno stanje je doseženo v 2 dneh.
Spironolactone is rapidly and completely metabolised by the liver into its active metabolites, 7αthiomethyl-spironolactone and canrenone, which are the primary metabolites in the dog. 
Spironolakton se hitro in v celoti metabolizira v jetrih v aktivna metabolita, 7α-tiometil-spironolakton in kanrenon, ki sta primarna metabolita pri psih.
Polyamide/aluminium/polyvinyl chloride//aluminium blisters containing 10 tablets. 
Poliamid/aluminij/polivinil klorid//aluminij pretisni omot z 10 tabletami.
Spironolactone is a natriuretic drug (historically described as a soft diuretic). 
Spironolakton je natriuretično zdravilo (poznan kot blag diuretik).
A reversible prostatic atrophy (reduction in size) is often observed in entire male dogs. 
Reverzibilna atrofija prostate ( redukcija v velikosti ) je pogosto opažena pri nekastriranih samcih.
Furosemide and pimobendan have been used together with Spironolactone Ceva in dogs with heart failure without any clinical evidence of adverse reactions. 
Furosemid in pimobendan sta bila uporabljena skupaj s Prilaktonom pri psih s srčno odpovedjo brez pojava kliničnih znakov neželenih učinkov.
Mean Cmax of 382 μg/l and 94 μg/l are achieved for the primary metabolites, 7αthiomethyl-spironolactone and canrenone, after 2 and 4 hours, respectively. 
Najvišjo Cmax 382 μg/l in 94 μg/l dosežeta primarna metabolita, 7α-tiometil-spironolakton in kanrenon, po 2 in 4 urah.
Do not use during pregnancy or lactation. 
Ne uporabite v obdobju brejostji in laktacije.
The renal effects of spironolactone and its metabolites lead to a decrease in extracellular volume and consequently in a decrease of cardiac preload and left atrial pressure. 
Učinki spironolaktona in njegovih metabolitov v ledvicah vodijo do zmanjšanja ekstracelularnega volumna in posledično do zmanjšanega pritoka v srce in pritiska v levem atriju.
Dogs treated concomitantly with spironolactone and NSAIDs should be correctly hydrated. 
Psi, ki so stalno zdravljeni z spironolaktoni in NSAID (nesteroidno protivnetno zdravilo) morajo biti ustrezno hidrirani.
White HDPE bottle containing 30 tablets with a white polypropylene child-resistant tamper-evident screw cap fitted with a desiccant insert, packaged in a cardboard box. 
Bel HDPE vsebnik, ki vsebuje 30 tablet, z belim polipropilenskim, za otroke varnim, pokrovčkom, opremljen s sušilnim vložkom, pakiran v kartonski škatli.
Sodium laurilsulfate Microcrystalline cellulose Povidone 
Natrijev lavrilsulfat Mikrokristakna celuloza Povidon
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION 
ODMERKI ZA POSAMEZNE ŽIVALSKE VRSTE TER POT(I) IN NAČIN UPORABE ZDRAVILA Peroralna uporaba.
30 tablets 180 tablets 
180 tablet
Use within 2 months after first opening the bottle. 
2 meseca po prvem odprtju vsebnika.
In the kidney, spironolactone inhibits the aldosterone-induced sodium retention leading to increase in sodium and subsequently water excretion, and potassium retention. 
V ledvicah spironolakton inhibira aldosteronsko inducirano zadrževanje natrija, kar vodi k zvečanemu izločanju natrija in posledično izločanju vode in zadrževanju kalija.
A slight increase in aldosterone blood levels may be observed in animals on treatment. 
Pri zdravljenih živalih se lahko opazi rahlo povišanje nivoja krvnega aldosterona.
Concomitant administration of spironolactone with ACE-inhibitors and other potassium-sparing drugs (as angiotensin receptor blockers, ß-blockers, calcium channels blockers, etc) may potentially lead to hyperkalaemia (see section "Special precautions for use in animals"). 
Hkratno dajanje spironolaktona z inhibitorji ACE in drugimi s kalijem revnimi zdravili (kot blokatorji angiotenzinskih receptorjev, ß-blokatorji, blokatorji kalcijevih kanalov, itd..) lahko privede do hiperkaliemije (glej poglavje "Posebni previdnostni ukrepi za uporabo pri živalih").
The administration of either deoxycorticosterone or NSAIDs with spironolactone may lead to a moderate reduction of the natriuretic effects (reduction of urinary sodium excretion) of spironolactone. 
Aplikacija deoxykortikosteronov ali NSAID(nesteroidno protivnetno zdravilo) s spironolaktonom lahko povzroči zmerno znižanje natridiuretičnega učinka spironolaktona (zmanjšano izločanje natrija z urinom).
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. 
6.6 Posebni varnostni ukrepi za odstranjevanje neporabljenega zdravila ali odpadnih snovi Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi..
Concomitant administration of spironolactone with ACE-inhibitors and other potassium-sparing drugs (as angiotensin receptor blockers, ß-blockers, calcium channels blockers…etc) may potentially lead to hyperkalaemia (see section 4.5). 
Hkratna aplikacija spironolaktona z inhibitorji ACE in drugimi s kalijem revnimi zdravili (kot blokatorji angiotenzinskih receptorjev, ß-blokatorji, blokatorji kalcijevih kanalov itd) lahko privede do hiperkaliemije (glej poglavje 4.5).
As the therapeutic index for digoxin is very narrow, it is advisable to monitor closely dogs receiving both digoxin and spironolactone. 
Ker je terapevtski indeks digoksina zelo ozek, je priporočljivo spremljati stanje živali, ki je zdravljenaz digoksinom in spironolaktonom.
As spironolactone has an antiandrogenic effect, it is not recommended to administer the veterinary medicinal product to growing dogs. 
Ker ima spironolakton antiandrogen učinek, ni priporočljiva uporaba zdravila za uporabo v veterinarski medicini pri rastočih psih.
The veterinary medicinal product should be administered with food. 
Zdravilo za uporabo v veterinarski medicini se da primešano v hrano.
Bottle containing 30 tablets packed in a cardboard box. 
Velikost pakiranja: Vsebnik s 30 tabletami v kartonski škatli.
SPECIAL WARNING(S), IF NECESSARY 
POSEBNO(A) OPOZORILO(A), ČE JE/SO POTREBNO(A) Pred uporabo preberite navodilo za uporabo
MANUFACTURER'S BATCH NUMBER 
IZDELOVALČEVA ŠTEVILKA SERIJE Lot :
METHOD AND ROUTE(S) OF ADMINISTRATION 
NAČIN IN POT(I) UPORABE Peroralna uporaba
May cause skin sensitisation: people with known hypersensitivity to spironolactone should avoid contact with the veterinary medicinal product. 
Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo Lahko povzroča kožne reakcije: osebe z znano preobčutljivostjo na spironolakton naj se izogibajo stiku z zdravilom za uporabo v veterinarski medicini.
Cardboard box of 1 bottle of 30 tablets 
PODATKI NA ZUNANJI OVOJNINI Kartonasta škatla z 1 vsebnikom s 30 tabletami
A reversible prostatic atrophy is often observed in entire male dogs. 
Reverzibilna atrofija prostate je pogosto opažena pri nekastriranih samcih.
Kidney function and serum potassium levels should be evaluated before initiating combined treatment with spironolactone and Angiotensin Converting Enzyme (ACE) inhibitors. 
Posebni previdnostni ukrepi za uporabo pri živalih Pred začetkom kombiniranega zdravljenja s spironolaktonom in inhibitorji angiotenzin konvertirajočega encima (ACE) je treba oceniti ledvično funkcijo in nivo serumskega kalija.
However, in dogs with renal impairment regular monitoring of renal function and serum potassium levels is recommended as there may be an increased risk of hyperkalaemia. 
Vendar pa pri psih z ledvično oslabelostjo obstaja tveganje hiperkaliemije in se zato priporoča redni monitoring ledvične funkcije in nivoja serumskega kalija.
Symptomatic treatment, e.g., fluid therapy, should be provided. 
Priporočljiva je simptomatska terapija kot so infuzije.
Blister - 10 mg tablets, 40 mg tablets and 80 mg tablets 
Pretisni omot - 10 mg tablete, 40 mg tablete in 80 mg tablete
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs 
DODATEK II A. IMETNIK(I) DOVOLJENJ(A) ZA IZDELAVO ZDRAVILA, ODGOVOREN(ODGOVORNI) ZA SPROŠČANJE SERIJE B. POGOJI DOVOLJENJA ZA PROMET Z ZDRAVILOM TER OMEJITVE GLEDE OSKRBE IN UPORABE C. NAVEDBA NAJVIŠJIH DOVOLJENIH KOLIČIN OSTANKOV ZDRAVILA (MRL) D. DRUGI POGOJI IN ZAHTEVE KI JIH MORA IZPOLNITI IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM
D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION 
DRUGI POGOJI IN ZAHTEVE, KI JIH MORA IZPOLNITI IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM
After administration of up to 10 times the recommended dose (20 mg/kg) to healthy dogs, dosedependent adverse effects were noted (see section "Adverse Reactions"). 
Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) Po dajanju preko 10-kratnega priporočenega odmerka (20 mg/kg) zdravemu psu, so opazili neželene učinke odvisne od odmerka, (glej poglavje "Neželeni učinki")..
Cardboard box - 10 mg tablets, 40 mg tablets and 80 mg tablets 
PODATKI NA ZUNANJI OVOJNINI Kartonasta škatla - 10 mg tablete, 40 mg tablete in 80 mg tablete
After administration of up to 10 times the recommended dose (20 mg/kg) to healthy dogs, dosedependent adverse effects were noted (see section 4.6). 
4.10 Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) Po administraciji preko 10-kratnega priporočenega odmerka (20 mg/kg) zdravemu psu, so opazili neželene učinke odvisne od odmerka (glej poglavje 4.6).
Do not use in animals used for, or intended for use in breeding. 
Ne uporabite pri vzrejnih živalih.
EXP: {month/year} Partially used tablets to be used within 7 days. 
Rok uporabnosti delno uporabljenih tablet je 7 dni.
OTHER INFORMATION Pack size: 
Velikost pakiranja:
EXP: {month/year} Use within 2 months after first opening the bottle. 
Po prvem odprtju vsebnika uporabite v 2 mesecih.
As spironolactone undergoes extensive hepatic biotransformation, care should be taken when using the veterinary medicinal product to treat dogs with hepatic dysfunction. 
Ker je spironolakton podvržen intenzivni jetrni biotransformaciji, je je potebna previdnost, kadar se z zdravilom za uporabo v veterinarski medicini zdravi pse z jetrno disfunkcijo.
When used in combination with ACE-inhibitors, spironolactone may counteract the effects of “aldosterone escape”. 
Pri istočasni uporabi z inhibitorji ACE pride lahko do pojava, ki mu rečemo “ pobeg aldosterona”
Bottle of 30 tablets 
Vsebnik s 30 tabletami
Spironolactone Ceva 80 mg: White, with a slight brownish mottling, oval tablet of 20 mm length with three parallel break-lines. 
Spironolactone Ceva 80 mg: Bela, z rjavkasto prevleko, ovalna tableta dolžine 20 mm s tremi paralelnimi zarezami.
Spironolactone Ceva 10 mg contains 10 mg spironolactone Spironolactone Ceva 40 mg contains 40 mg spironolactone Spironolactone Ceva 80 mg contains 80 mg spironolactone 
Spironolactone Ceva 10 mg vsebuje 10 mg spironolaktona Spironolactone Ceva 40 mg vsebuje 40 mg spironolaktona Spironolactone Ceva 80 mg vsebuje 80 mg spironolaktona
Lot: {number} 
ŠTEVILKA SERIJE Lot:{xxxxx}
Shelf life of the veterinary medicinal product as packaged for sale: 3 years Partially used tablets to be used within 7 days. 
Rok uporabnosti zdravila v pakiranju za prodajo je 3 leta.
BODYWEIGHT Spironolactone Ceva 10 mg 
TELESNA MASA Spironolactone Ceva 10 mg
Spironolactone Ceva tablets are used in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs. 
Zmanjšanje kardiovaskularnih poškodb pri kongestivni odpovedi srca povzročeni zaradi valvularne regurgitacije pri psih v kombinaciji s standardno terapijo, ki vključuje diuretično podporo, če je potrebno.
EU/2/07/074/005 (3 blisters of 10 tablets) EU/2/07/074/006 (18 blisters of 10 tablets) 
EU/2/07/074/005 (3 pretisni omoti po 10 tablet) EU/2/07/074/006 (18 pretisnih omotov po 10 tablet)
EU/2/07/074/001 (3 blisters of 10 tablets) EU/2/07/074/002 (18 blisters of 10 tablets) 
EU/2/07/074/001 (3 pretisni omoti po 10 tablet) EU/2/07/074/002 (18 pretisnih omotov po 10 tablet)
The mean residence time of the metabolites ranges from 9 to 14 hours and they are preferentially distributed to the gastro-intestinal tract, kidney, liver and adrenal glands. 
Distribuirajo se v gastrointestinalni trakt, ledvice, jetra in nadledvične žleze.
EU/2/07/074/003 (3 blisters of 10 tablets) EU/2/07/074/004 (18 blisters of 10 tablets) 
EU/2/07/074/003 (3 pretisni omoti po 10 tablet) EU/2/07/074/004 (18 pretisnih omotov po 10 tablet)
NAME OF THE MARKETING AUTHORISATION HOLDER 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM CEVA
Spironolactone 10 mg Spironolactone 40 mg Spironolactone 80 mg 
KOLIČINA ZDRAVILNE(IH) UČINKOVIN(E) spironolactone 10 mg spironolactone 40 mg spironolactone 80 mg
Marketing authorisation holder: 
NAVODILO ZA UPORABO:
MARKETING AUTHORISATION HOLDER 
IMETNIKDOVOLJENJA ZA PROMET
Spironolactone Ceva 40 mg: White, with a slight brownish mottling, oval tablet of 17 mm length with three parallel break-lines. 
Spironolactone Ceva 10 mg: Bela, z rjavkasto prevleko, na pol deljiva ovalna tableta dolžine 10 mm. Spironolactone Ceva 40 mg: Bela, z rjavkasto prevleko, ovalna tableta dolžine 17 mm s tremi paralelnimi zarezami.
Monitoring of their renal function and plasma potassium levels is recommended before initiation and during treatment with combined therapy (see section 4.3). 
Potreben je reden monitoring njihovega delovanja ledvic in nivo serumskega kalija pred in med zdravljenjem s kombinirano terapijo.
Monitoring of their renal function and plasma potassium levels is recommended before initiation and during treatment with combined therapy (see section "Contraindications"). 
Potreben je reden monitoring njihovega delovanja ledvic in nivoja serumskega kalija pred in med zdravljenjem s kombinirano terapijo.
After multiple oral doses of 2 mg spironolactone/ kg for 10 consecutive days, no accumulation is observed. 
Po večkratnih peroralnih odmerkih 2 mg spironolaktona/kg t.m.
Partially used tablets should be stored in the original blister. 
Deli tablet se morajo hraniti v originalnem pretisnem omotu.
Spironolactone Ceva 10 mg tablets for dogs Spironolactone Ceva 40 mg tablets for dogs Spironolactone Ceva 80 mg tablets for dogs Spironolactone. 
Spironolactone Ceva 10 mg tablete za pse Spironolactone Ceva 40 mg tablete za pse Spironolactone Ceva 80 mg tablete za pse Spironolakton.
Spironolactone Ceva 10 mg tablets for dogs Spironolactone Ceva 40 mg tablets for dogs Spironolactone Ceva 80 mg tablets for dogs spironolactone 
Spironolactone Ceva 10 mg tablete za pse Spironolactone Ceva 40 mg tablete za pse Spironolactone Ceva 80 mg tablete za pse Spironolakton
Store partially used tablets in the original blister. 
POSEBNA NAVODILA ZA SHRANJEVANJE Delno uporabljene tablete shranjujte v originalnem pretisnem omotu.
QUANTITY OF THE ACTIVE SUBSTANCE(S) 
NAVEDBA ZDRAVILNE(IH) UČINKOVIN(E) IN DRUGIH SNOVI Spironolakton 10 mg
Spironolactone Ceva 40 mg : Brown bisected oval tablet of 17 mm length Spironolactone Ceva 80 mg : Brown quadrisected oval tablet of 20 mm length 
Spironolactone Ceva 10 mg: Rjava, na pol deljiva ovalna tableta dolžine 10 mm. Spironolactone Ceva 40 mg: Rjava, na pol deljiva ovalna tableta dolžine 17 mm. Spironolactone Ceva 80 mg: Rjava, na štiri dele deljiva ovalna tableta dolžine 20 mm.
AUTHORISATION 
Francija
Partially used tablets should be stored in the original bottle. 
Deli tablet se morajo hraniti v originalnem vsebniku.
Time, hours 
Čas, ure
Have you recently become ill? 
- Ali ste morda nedavno zboleli?
Time to maximum concentration was also similar between formulations. 
Tudi čas do najvišje koncentracije je bil med formulacijama podoben.
This can be caused if: 
Do tega lahko pride, če:
Time (hr) 
Čas (ure) (hr)
White suspension. 
Bela suspenzija.
The target audience and the modalities for distribution all of these materials are to be agreed at Member State level. 
Dogovori o ciljni skupini in načinih distribucije vseh teh gradiv bodo sklenjeni na ravni države članice.
Do not expose to excessive heat or direct sunlight. 
Ne izpostavljajte čezmerni vročini ali neposredni sončni svetlobi.
This might just be for the first injection or it may be a gradual change over several weeks or months. 
To lahko velja le za prvo injekcijo ali pa bo šlo za postopno spremembo skozi več tednov ali celo mesecev.
You may give an infection to them or get an infection from them. 
S tem bi jim lahko prenesli okužbo ali pa bi dobili okužbo od njih.
Are you exercising more than usual? 
− Ali ste telesno dejavnejši kot običajno?
The insulin should look evenly mixed. 
Insulin mora biti videti enakomerno premešan.
• Always carry sugar with you. 
• S seboj imejte vedno tudi nekaj sladkorja.
He will only do this under special circumstances such as surgery or if you are ill and your glucose levels are too high. 
To bo naredil samo v posebnih okoliščinah, kot je operacijski poseg ali če ste bolni in so vaše ravni glukoze previsoke.
The symptoms are as follows: 
Simptomi so naslednji:
(Needles are not included). 
(Igle niso priložene.)
- Your Needle may be blocked. 
- morda je vaša igla zamašena.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. 
Viala Zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjena v poglavju 6.6.
Therefore the amount of insulin needed may change. 
Zato se količina potrebnega insulina lahko spremeni.
The patient communication should address the following key elements: 
Informacije za bolnike morajo zajemati naslednje ključne elemente:
The first symptoms come on slowly over many hours or days. 
Prvi simptomi se pojavijo postopoma v več urah ali celo dnevih.
The first symptoms of low blood sugar usually come on quickly and include the following: • tiredness 
Prvi simptomi nizkega krvnega sladkorja se običajno pojavijo hitro in vključujejo naslednje:
This pen is designed to allow you to give more doses than other pens you may have used in the past. 
Ta peresnik je zasnovan tako, da omogoča dajanje večjega števila odmerkov kot drugi peresniki, ki ste jih morda uporabljali v preteklosti.
The distance between each mark on the gauge is about 20 units. 
Razdalja med dvema oznakama na merilu je približno 20 enot.
It is a changed form of human insulin and so is different from other human and animal insulins. 
Gre za spremenjeno obliko humanega insulina, ki se razlikuje od drugih humanih in živalskih insulinov.
In addition, insulins have several anabolic and anti-catabolic actions on a variety of different tissues. 
Poleg tega ima insulin številne anabolične in antikatabolične učinke na različna tkiva.
Patients must be educated to use the proper injection techniques. 
Bolnike je treba naučiti uporabe pravilnih metod injiciranja.
Even when you are not eating normally, you still need insulin. 
Tudi če jeste manj kot običajno, še vedno potrebujete insulin.
See section 6.2. 
Glejte poglavje 6.2.
Adjustment of dosage may also be necessary if patients undertake increased physical activity or change their usual diet. 
Odmerjanje bo morda treba prilagoditi tudi, če bolnik poveča telesno dejavnost ali spremeni običajni način prehrane.
If mixing insulins, refer to the instructions for mixing that follow in Section (ii) and 6.2. 
Če insuline mešate, glejte navodila za mešanje, ki sledijo v poglavju (ii) in 6.2.
If not, repeat the above procedure until contents are mixed. 
Če ni takega videza, ponavljajte zgoraj opisani postopek, dokler sestavine niso zmešane.
Severe symptoms are heavy breathing and a rapid pulse. 
Hudi simptomi so težko dihanje in hitro bitje srca.
Warning signs are listed in section 4 of this leaflet. 
Opozorilni znaki so našteti v poglavju 4 teh navodil.
Mixing is important to make sure you get the right dose. 
Mešanje je pomembno za zagotovitev pravilnega odmerka.
Glucose Infusion Rate (mg/min) 
Hitrost infuzije glukoze (mg/min)
Speak to your doctor if this applies to you. 
Posvetujte se z zdravnikom, če to velja za vas.
Severe hypoglycaemia may lead to loss of consciousness, and in extreme cases, death. 
Huda hipoglikemija lahko vodi v izgubo zavesti, v skrajnih primerih pa celo v smrt.
General information about the safe and effective use of your pen 
Splošne informacije o varni in učinkoviti uporabi vašega peresnika
But your doctor will have told you exactly how much to use, when to use it, and how often. 
Zdravnik vam bo povedal, natančno koliko zdravila potrebujete, kdaj ga uporabite in kako pogosto.
Frequent monitoring of the blood glucose levels is required. 
Potrebno je pogosto spremljanje ravni glukoze v krvi.
Ask your doctor to tell you about glucagon. 
Zdravnika prosite, naj vam pove kaj več o glukagonu.
• The amount of insulin you need may also change if you drink alcohol. 
• Količina potrebnega insulina se lahko spremeni tudi, če pijete alkoholne pijače.
This leaflet was last revised in {MM/YYYY}. 
Navodilo je bilo nazadnje revidirano {MM/YYYY}.
Speak to your doctor if you need to inject your insulin by another method. 
Pogovorite se s svojim zdravnikom, če si morate insulin injicirati na drug način.
It is recommended that the system is primed before starting the infusion to the patient. 
Priporočeno je, da se sistem pred začetkom infundiranja bolniku pripravi.
• cold sweat. 
• hladen znoj.
2 units. 
20 enot.
• Always use a new Needle for each injection to help prevent infections and blocked Needles. 
• Vedno uporabite novo iglo za vsako injiciranje, da boste pomagali preprečiti okužbe in zamašenost igle.
In one clinical study there was a small (0.38 mmol/l) increase in blood glucose levels at night (3a.m. 
V eni klinični študiji je bil majhen (0.38 mmol/l) porast ravni glukoze merjene ponoči (3:00 zjutraj).
In some studies, reduction of nocturnal hypoglycaemia was associated with increased episodes of daytime hypoglycaemia. 
V nekaterih študijah je bilo znižanje števila nočnih hipoglikemij povezano s povišanjem števila dnevnih hipoglikemij.
• eating a lot more than your diet allows; or 
•pojedli ste veliko več, kot predpisuje vaša dieta; ali
• You will set the dose to 1 or 2 units. 
• Odmerek boste nastavili na 1 ali 2 enoti.
This is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. 
To je še posebno pomembno pri tistih, ki se manj ali sploh ne zavedajo opozorilnih znakov hipoglikemije ali imajo pogoste hipoglikemije.
Subcutaneous and intravenous use 
Za subkutano in intravensko uporabo
ATC Code: A10A D04. 
Oznaka ATC: A10A D04.
Do not put it near heat or in the sun. 
Ne puščajte ga v bližini virov toplote ali na soncu.
It will not affect your dose. 
Ta kapljica ne bo vplivala na vaš odmerek.